Article

Direct plating of rectal cultures improves sensitivity

A screening protocol to guide antibiotic prophylaxis prior to prostate biopsy that eliminates the broth enrichment provides the best sensitivity with the fewest false- positive rates.

Newsletter

Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.

Subscribe Now!
Related Videos
Jennifer Robles, MD, on trends and regional disparities in HoLEP utilization
Jennifer Robles, MD, on trends and regional disparities in HoLEP utilization
Aleece Fosnight, MSPAS, PA-C, CSC-S, CSE, IF, MSCP, HAES, answers a question during a Zoom video interview
Aleece Fosnight, MSPAS, PA-C, on treating women with eating disorders and bladder dysfunction
Doctor talking with patient | Image Credit: © Pcess609 - stock.adobe.com
TRT delivery: A urologist discusses options and patient preferences
Joseph Song, MD, describes his experience using the CVAC device
Joseph Song, MD, describes his experience using the CVAC device
Experts assess pre-operative factors linked with buccal mucosa graft failure
Experts assess pre-operative factors linked with buccal mucosa graft failure
Interim Results from ADVANCED 2
Interim Results from ADVANCED 2
DNA molecules | Image Credit: © vitstudio - stock.adobe.com
Integrating ctDNA in NMIBC: Promise and practical challenges
TARA-002 mechanism of action
TARA-002 mechanism of action
Robert Jansen, MD, answers a question during a Zoom video interview
Robert Jansen, MD, discusses evaluation of candidates for testosterone therapy
Ashley Winter, MD, discusses testosterone therapy for women
Ashley Winter, MD, discusses testosterone therapy for women
Related Content
New study uncovers how prostate cancer becomes deadly and offers hope for new treatments
August 6th 2025

New study uncovers how prostate cancer becomes deadly and offers hope for new treatments

Emory Urology
A first-of-its kind study led by Emory researchers uncovered how prostate cancer transforms into its most lethal form — and identified a promising new treatment strategy.
Pearls & Perspectives: Tailoring BPH Therapies to the Patient, with Utsav Bansal, MD
August 6th 2025

Pearls & Perspectives: Tailoring BPH Therapies to the Patient, with Utsav Bansal, MD

Amy M. Pearlman, MD
Bansal unpacks how to personalize treatment plans in a therapeutic landscape now filled with minimally invasive and surgical options.
Updated EVISION data show sustained efficacy of mitomycin intravesical solution for LG-IR-NMIBC
August 6th 2025

Updated EVISION data show sustained efficacy of mitomycin intravesical solution for LG-IR-NMIBC

Hannah Clarke
Treatment with mitomycin for intravesical solution led to a 24-month DOR of 72.2% among patients who achieved an initial complete response.
Pearls & Perspectives: Testosterone and the Future of Men’s Health, with John P. Mulhall, MD
August 6th 2025

Pearls & Perspectives: Testosterone and the Future of Men’s Health, with John P. Mulhall, MD

Amy M. Pearlman, MD
Mulhall offers an unfiltered, evidence-based deep dive into testosterone evaluation and treatment nuances.
Pembrolizumab plus axitinib shows sustained benefit vs sunitinib in ccRCC
August 6th 2025

Pembrolizumab plus axitinib shows sustained benefit vs sunitinib in ccRCC

Hannah Clarke
Five-year data from the phase 3 KEYNOTE-426 trial confirm the clinical benefits of front-line pembrolizumab plus axitinib in advanced ccRCC.
Phase 1/2 trial of INKmune therapy for mCRPC meets primary end point
August 6th 2025

Phase 1/2 trial of INKmune therapy for mCRPC meets primary end point

Hannah Clarke
INKmune was well-tolerated across all 3 dose levels assessed.
© 2025 MJH Life Sciences

All rights reserved.